NCT05799612 2026-02-13Phase I Study of TH1 Dendritic Cell Immunotherapy for the Treatment of Cutaneous AngiosarcomaM.D. Anderson Cancer CenterPhase 1 Withdrawn
NCT06440005 2026-02-11A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid TumorsAngiex, Inc.Phase 1 Recruiting80 enrolled
NCT05859074 2025-12-03A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor CancerMemorial Sloan Kettering Cancer CenterPhase 1 Recruiting56 enrolled